Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
Clinical trial NCT07243691 · RECRUITING
Trial details
- NCT number
- NCT07243691
- Sponsor
- Sir Run Run Shaw Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.